Market research
USJ.F USANA Health Sciences, Inc
F EUR Consumer Defensive
Latest close
Loading market data…
Test a moving-average rule with historical data.
Market facts
- P/E ratio
- Not available
- Analyst target
- 95
- Dividend yield
- Not available
- Beta
- 0.68
Profile
Company facts
- Exchange
- F
- Currency
- EUR
- Sector
- Consumer Defensive
- Industry
- Packaged Foods
- ISIN
- Not available
- P/E ratio
- Not available
- Analyst target
- 95
- Dividend yield
- Not available
- Beta
- 0.68
About
About USANA Health Sciences, Inc
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Core nutritional and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essentials/CellSentials, such as vitamin and mineral supplements for age group beginning with children 13 months of age; and food products that include meal replacement shakes, snack bars, and other related products for healthy weight management, digestive health, and energy and hydration. It offers Celavive, a skincare regimen for various skin care types and ethnicities; and all other products comprising materials and online tools for associates to build business and marketing of products The company sells its products through retail customers, a subscription model, and direct selling, as well as online. The company was founded in 1992 and is headquartered in Salt Lake City, Utah.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the USJ.F discussion.
5 years, 6 months ago
USANA Health Sciences, Inc is currently in a long term uptrend where the price is trading 12.0% above its 200 day moving average.
From a valuation standpoint, the stock is 98.3% cheaper than other stocks from the Consumer Defensive sector with a price to sales ratio of 1.9.
USANA Health Sciences, Inc's total revenue rose by 14.5% to $311M since the same quarter in the previous year.
Its net income has increased by 28.9% to $40M since the same quarter in the previous year.
Finally, its free cash flow fell by 8.1% to $46M since the same quarter in the previous year.
Based on the above factors, USANA Health Sciences, Inc gets an overall score of 4/5.